Suchergebnisse - Fabian Finkelmeier
- Treffer 1 - 20 von 23
- Zur nächsten Seite
-
1
-
2
Severe 25‐hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma – a prospective cohort study von Fabian Finkelmeier, Bernd Kronenberger, Verena Köberle, Jörg Bojunga, Stefan Zeuzem, Jörg Trojan, Albrecht Piiper, Oliver Waidmann
Veröffentlicht 2014Artigo -
3
Efficacy and Safety of Atezolizumab and Bevacizumab in the Real-World Treatment of Advanced Hepatocellular Carcinoma: Experience from Four Tertiary Centers von Vera Himmelsbach, Matthias Pinter, Bernhard Scheiner, Marino Venerito, Friedrich Sinner, Carolin Zimpel, Jens U. Marquardt, Jörg Trojan, Oliver Waidmann, Fabian Finkelmeier
Veröffentlicht 2022Artigo -
4
Colonization with multidrug resistant organisms determines the clinical course of patients with acute myeloid leukemia undergoing intensive induction chemotherapy von Olivier Balló, Ikram Tarazzit, Jan A. Stratmann, Claudia Reinheimer, Michael Hogardt, Thomas A. Wichelhaus, Volkhard A. J. Kempf, Hubert Serve, Fabian Finkelmeier, Christian Brandts
Veröffentlicht 2019Artigo -
5
-
6
Serum Autotaxin Is a Parameter for the Severity of Liver Cirrhosis and Overall Survival in Patients with Liver Cirrhosis – A Prospective Cohort Study von Thomas Pleli, Daniel Martin, Bernd Kronenberger, Friederike Brunner, Verena Köberle, Georgios Grammatikos, Harald Farnik, Yolanda Martínez, Fabian Finkelmeier, Sandra Labocha, Nerea Ferreirós, Stefan Zeuzem, Albrecht Piiper, Oliver Waidmann
Veröffentlicht 2014Artigo -
7
Real-world effectiveness of voxilaprevir/velpatasvir/sofosbuvir in patients following DAA failure von Christiana Graf, Roberta D’Ambrosio, Elisabetta Degasperi, Stefania Paolucci, Jordi Llaneras, Johannes Vermehren, G. Dultz, Kai‐Henrik Peiffer, Fabian Finkelmeier, Eva Herrmann, Stefan Zeuzem, Marı́a Buti, Pietro Lampertico, Julia Dietz, Christoph Sarrazin
Veröffentlicht 2024Artigo -
8
EphrinB2 repression through ZEB2 mediates tumour invasion and anti-angiogenic resistance von Cornelia Depner, H. zum Buttel, Nuray Böğürcü, Ángel M. Cuesta, María R. Aburto, Sascha Seidel, Fabian Finkelmeier, Franziska Foss, Jennifer Hofmann, Kerstin Kaulich, Sebastian Barbus, Marta Segarra, Guido Reifenberger, Boyan K. Garvalov, Till Acker, Amparo Acker‐Palmer
Veröffentlicht 2016Artigo -
9
Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade von Claire Conche, Fabian Finkelmeier, Marina Pešić, Adele M. Nicolas, Tim W. Böttger, Kilian B. Kennel, Dominic Denk, Fatih Ceteci, Kathleen Mohs, Esther Engel, Özge Canli, Yasamin Dabiri, Kai‐Henrik Peiffer, Stefan Zeuzem, Gabriela Salinas, Thomas Longerich, Huan Yang, Florian R. Greten
Veröffentlicht 2023Artigo -
10
Programmed cell death protein‐1 (<scp>PD</scp>‐1)‐targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real‐world... von Bernhard Scheiner, Martha M. Kirstein, Florian Hucke, Fabian Finkelmeier, Kornelius Schulze, Johann von Felden, Sandra Koch, Philipp Schwabl, Jan B. Hinrichs, Fredrik Waneck, Oliver Waidmann, Thomas Reiberger, Christian Müller, Wolfgang Sieghart, Michael Trauner, Arndt Weinmann, Henning Wege, Jörg Trojan, Markus Peck‐Radosavljevic, Arndt Vogel, Matthias Pinter
Veröffentlicht 2019Artigo -
11
Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort von Fabian Finkelmeier, Bernhard Scheiner, Catherine Leyh, Jan Best, Thorben Fründt, Carolin Czauderna, Alica K. Beutel, Dominik Bettinger, Johannes Weiß, Tobias Meischl, Fabian Kütting, Dirk‐Thomas Waldschmidt, Pompilia Radu, Michael Schultheiß, Kai‐Henrik Peiffer, Thomas Jens Ettrich, Arndt Weinmann, Henning Wege, Marino Venerito, Jean‐François Dufour, Christian M. Lange, Matthias Pinter, Oliver Waidmann
Veröffentlicht 2021Artigo -
12
Secondary Sclerosing Cholangitis Following Coronavirus Disease 2019 (COVID-19): A Multicenter Retrospective Study von Peter Hunyady, Lea Streller, Darius F. Rüther, Sara Reinartz Groba, Dominik Bettinger, Daniel Fitting, Karim Hamesch, Jens U. Marquardt, Victoria T. Mücke, Fabian Finkelmeier, Asieb Sekandarzad, Tobias Wengenmayer, Ayoub Bounidane, Felicitas Weiss, Kai-Henrik Peiffer, Bernhard Schlevogt, Stefan Zeuzem, Oliver Waidmann, Marcus Hollenbach, Martha M. Kirstein, Johannes Kluwe, Fabian Kütting, Marcus M. Mücke
Veröffentlicht 2022Artigo -
13
Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A Retrospective Multicenter Study von Sabrina Welland, Catherine Leyh, Fabian Finkelmeier, André Jefremow, Kateryna Shmanko, Maria A. González-Carmona, Arne Kandulski, Petia Jeliazkova, Jan Best, Thorben Fründt, Angela Djanani, Maria Pangerl, A Maieron, Richard Greil, Christina Fricke, Disorn Sookthai, Rainer Günther, Andreas Schmiderer, Henning Wege, Marino Venerito, Ursula Ehmer, Martina Müller, Christian P. Strassburg, Arndt Weinmann, Jürgen Siebler, Oliver Waidmann, Christian M. Lange, Anna Saborowski, Arndt Vogel
Veröffentlicht 2022Artigo -
14
Unveiling the diagnostic enigma of D‐dimer testing in cancer patients: Current evidence and areas of application von Jennifer Gotta, Leon D. Gruenewald, Katrin Eichler, Simon S. Martin, Scherwin Mahmoudi, Christian Booz, Teodora Biciusca, Philipp Reschke, Simon Bernatz, Daniel Pinto dos Santos, Jan‐Erik Scholtz, Leona S. Alizadeh, Nour‐Eldin A. Nour‐Eldin, Renate Hammerstingl, Tatjana Gruber‐Rouh, Christoph Mader, Stefan E. Hardt, Christof M. Sommer, Giuseppe M. Bucolo, Tommaso D’Angelo, Melis Onay, Fabian Finkelmeier, David M. Leistner, Thomas J. Vogl, Evangelos Giannitsis, Vitali Koch
Veröffentlicht 2023Revisão -
15
Terlipressin therapy is associated with increased risk of colonisation with multidrug‐resistant bacteria in patients with decompensated cirrhosis von Marcus M. Mücke, María Hernández‐Tejero, Wen Gu, Michael W.M. Kühn, Malte Janz, M. Keller, Anthony Fullam, Laura Altepeter, Victoria T. Mücke, Fabian Finkelmeier, Katharina Schwarzkopf, Carla Cremonese, Peter‐Merton Hunyady, Myriam Heilani, Frank Erhard Uschner, Robert Schierwagen, Maximilian Joseph Brol, Julia Fischer, Sabine Klein, Kai‐Henrik Peiffer, Michael Hogardt, Saeed Shoaie, Minneke J. Coenraad, Jörg Bojunga, Vicente Arroyo, Stefan Zeuzem, Volkhard A. J. Kempf, Christoph Welsch, Wim Laleman, Peer Bork, Javier Fernández, Jonel Trebicka
Veröffentlicht 2024Artigo -
16
A faecal microbiota signature with high specificity for pancreatic cancer von Ece Kartal, Thomas Schmidt, Esther Molina‐Montes, Sandra Rodríguez, Jakob Wirbel, Oleksandr M. Maistrenko, Wasiu Akanni, Bilal Alashkar Alhamwe, Renato Alves, Alfredo Carrato, Hans‐Peter Erasmus, Lidia Estudillo, Fabian Finkelmeier, Anthony Fullam, Anna M Glazek, Paulina Gomez‐Rubio, Rajna Hercog, Ferris Jung, Stefanie Kandels‐Lewis, Stephan Kersting, Melanie Langheinrich, Mirari Márquez, Xavier Molero, Askarbek Orakov, Thea Van Rossum, Raúl Torres, Anja Telzerow, Konrad Zych, Vladimı́r Beneš, Georg Zeller, Jonel Trebicka, Francisco X. Real, Núria Malats, Peer Bork
Veröffentlicht 2022Artigo -
17
Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma von Philipp K. Haber, Florian Castet, Miguel Torres‐Martín, Carmen Andreu-Oller, Marc Puigvehí, Maeda Miho, Pompilia Radu, Jean‐François Dufour, Chris Verslype, Carolin Zimpel, Jens U. Marquardt, Peter R. Galle, Arndt Vogel, Melanie Bathon, Tim Meyer, Ismaïl Labgaa, Antonia Digklia, Lewis R. Roberts, Mohamed A. Mohamed Ali, Beatriz Mínguez, Davide Citterio, Vincenzo Mazzaferro, Fabian Finkelmeier, Jörg Trojan, Burcin Özdirik, Tobias Müller, Moritz Schmelzle, Anthony Bejjani, Max W. Sung, Myron Schwartz, Richard S. Finn, Swan N. Thung, Augusto Villanueva, Daniela Sia, Josep M. Llovet
Veröffentlicht 2022Artigo -
18
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score von Bernhard Scheiner, Katharina Pomej, Martha M. Kirstein, Florian Hucke, Fabian Finkelmeier, Oliver Waidmann, Vera Himmelsbach, Kornelius Schulze, Johann von Felden, Thorben Fründt, Marc Stadler, Harald Heinzl, Kateryna Shmanko, Stephan Spahn, Pompilia Radu, Alexander Siebenhüner, Joachim C. Mertens, Nuh N. Rahbari, Fabian Kütting, Dirk‐Thomas Waldschmidt, Matthias P. Ebert, Andreas Teufel, Sara De Dosso, David J. Pinato, Tiziana Pressiani, Tobias Meischl, Lorenz Balcar, Christian Müller, Mattias Mandorfer, Thomas Reiberger, Michael Trauner, Nicola Personeni, Lorenza Rimassa, Michael Bitzer, Jörg Trojan, Arndt Weinmann, Henning Wege, Jean‐François Dufour, Markus Peck‐Radosavljevic, Arndt Vogel, Matthias Pinter
Veröffentlicht 2021Artigo -
19
Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma von Bernhard Scheiner, Daniel Roessler, Samuel Phen, Mir Lim, Katharina Pomej, Tiziana Pressiani, Antonella Cammarota, Thorben Fründt, Johann von Felden, Kornelius Schulze, Vera Himmelsbach, Fabian Finkelmeier, Ansgar Deibel, Alexander Siebenhüner, Kateryna Shmanko, Pompilia Radu, Birgit Schwacha-Eipper, Matthias P. Ebert, Andreas Teufel, Angela Djanani, Florian Hucke, Lorenz Balcar, Alexander Philipp, David Hsiehchen, Marino Venerito, Friedrich Sinner, Michael Trauner, Antonio D’Alessio, Claudia Angela Maria Fulgenzi, David J. Pinato, Markus Peck‐Radosavljevic, Jean‐François Dufour, Arndt Weinmann, Andreas E. Kremer, Amit G. Singal, Enrico N. De Toni, Lorenza Rimassa, Matthias Pinter
Veröffentlicht 2022Artigo -
20
Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients von Mara Persano, Margherita Rimini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Jaekyung Cheon, Fabian Finkelmeier, Ho Yeong Lim, José Presa, Gianluca Masi, Changhoon Yoo, Sara Lonardi, Francesco Tovoli, Takashi Kumada, Naoya Sakamoto, Hideki Iwamoto, Tomoko Aoki, Hong Jae Chon, Vera Himmelsbach, Takashi Niizeki, Margarida Montes, Caterina Vivaldi, Caterina Soldà, Bernardo Stefanini, Atsushi Hiraoka, Takuya Sho, Naoshi Nishida, Christoph Steup, Massimo Iavarone, Giovanni Di Costanzo, Fabio Marra, Emiliano Tamburini, Giuseppe Cabibbo, Francesco Giuseppe Foschi, Marianna Silletta, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Hisashi Kosaka, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Claudia Campani, Elisabeth Amadeo, Federico Rossari, Valentina Burgio, Stefano Cascinu, Mario Scartozzi, Andrea Casadei‐Gardini
Veröffentlicht 2023Artigo
Suchwerkzeuge:
Ähnliche Schlagworte
Medicine
Internal medicine
Gastroenterology
Hepatocellular carcinoma
Cancer
Oncology
Biology
Immunotherapy
Cohort
Confidence interval
Adverse effect
Cancer research
Chemotherapy
Cirrhosis
Hazard ratio
Liver disease
Sorafenib
Bevacizumab
Genetics
Liver transplantation
Proportional hazards model
Transplantation
Atezolizumab
Disease
Gene
Immune checkpoint
Immune system
Immunology
Intensive care medicine
Lenvatinib